Summary
Updated Aug 30, 2026
Prattipati Laxminarain is Director of Microbot Medical Inc. (MBOT). 1 SEC Form 4 filing on record, dated 3 April 2026.
Trading Pattern
InsiderAlpha's records for Prattipati Laxminarain go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Most Active Insiders Right Now
Prattipati Laxminarain has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- GIC Private Ltd - $158.25M of MDLN open-market activity in the last 90 days
- Sean Lie - $157.48M of CBRS open-market activity in the last 90 days
- John B. Hess - $157.37M of CVX open-market activity in the last 90 days
- Mark Barrocas - $156.00M of SN open-market activity in the last 90 days
- Richard M. Schulze - $151.14M of BBY open-market activity in the last 90 days
- PLATINUM EQUITY, LLC - $150.00M of INGM open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Prattipati Laxminarain?
Prattipati Laxminarain is a corporate insider, tracked as Director of Microbot Medical Inc. (MBOT). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Prattipati Laxminarain last file a Form 4?
The only primary Form 4 on record is dated 3 April 2026.
Where can I see all of Prattipati Laxminarain's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Prattipati Laxminarain and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial